great thread everyone.
I only add one point
if all the fears validations and facts that you have pointed out arcu were no
longer issues the share price would be in the 5-10 dollar mark.
it's around a dollar because all these things haven't been answered.
this is a small cap speculative stock and is prices accordingly and has a fluctuation sp just like all other similar small caps in development.
you clearly don't have the risk apatite for something so fluid. I respect that.
but to all other poster, in my opinion if all these things were sorted out we would be looking at a $5 + sp. that's why I am invested in this. I have an apatite for this risk when I look at I am glad I got in at around 50c with 120k shares cause I know if and when such questions are answered I will not be selling for 60c, I will be selling a multi banger. if I wanted low risk slow return results I would have put that money in real estate.
this is hot copper and with respect people can throw stones at any company - but they rarely take account the current SP when they do. IMHO PIQ is priced perfectly by the market. it has nothing to do with management doing the right or wrong thing. we have no idea what's going on behind the scenes and can't! that would
look like insider trading.
some people take risks and accept the reality of those risks.
some people make investments in high risk stocks without being real with themselves about the risks and get frustrated when things don't go as they expect.
good luck acru. the big banks are a good investments. just don't expect a 10 banger there.
- Forums
- ASX - By Stock
- PIQ
- Ann: Proteomics bolsters executive team - CCO and CFO appointed
PIQ
proteomics international laboratories ltd
Add to My Watchlist
0.00%
!
29.0¢

Ann: Proteomics bolsters executive team - CCO and CFO appointed, page-59
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $47.42M |
Open | High | Low | Value | Volume |
30.5¢ | 30.5¢ | 28.5¢ | $187.1K | 634.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 81754 | 28.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 81754 | 0.280 |
4 | 147892 | 0.275 |
1 | 25000 | 0.270 |
1 | 10000 | 0.260 |
8 | 102003 | 0.250 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 1000 | 1 |
0.330 | 2000 | 1 |
0.345 | 1260 | 1 |
0.350 | 8000 | 1 |
0.360 | 35000 | 1 |
Last trade - 15.57pm 27/06/2025 (20 minute delay) ? |
Featured News
PIQ (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online